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ABSTRACT
SNARE proteins are essential components of the machinery that regulates 
vesicle trafficking and exocytosis. Their role is critical for the membrane-fusion 
processes that occur during neurotransmitter release. However, research in 
the last decade has also unraveled the relevance of these proteins in membrane 
expansion and cytoskeletal rearrangements during developmental processes such 
as neuronal migration and growth cone extension and attraction. Neurotrophins are 
neurotrophic factors that are required for many cellular functions throughout the 
brain, including neurite outgrowth and guidance, synaptic formation, and plasticity. 
Here we show that neurotrophin Trk receptors form a specific protein complex with 
the t-SNARE protein Syntaxin 1, both in vivo and in vitro. We also demonstrate 
that blockade of Syntaxin 1 abolishes neurotrophin-dependent growth of axons in 
neuronal cultures and decreases exocytotic events at the tip of axonal growth cones. 
25-kDa soluble N-ethylmaleimide-sensitive factor attachment protein and Vesicle-
associated membrane protein 2 do not participate in the formation of this SNARE 
complex, while tetanus neurotoxin-insensitive vesicle-associated membrane protein 
interacts with Trk receptors; knockdown of this (v) SNARE impairs Trk-dependent 
outgrowth. Taken together, our results support the notion that an atypical SNARE 
complex comprising Syntaxin 1 and tetanus neurotoxin-insensitive vesicle-associated 
membrane protein is required for axonal neurotrophin function.
INTRODUCTION
The plasma-membrane target (t) SNARE Syntaxin 
1 (Sytx1), the 25-kDa soluble N-ethylmaleimide-sensitive 
factor attachment protein (SNAP25), and the vesicle (v)-
associated membrane proteins VAMP2 and TI-VAMP are 
present in axonal growth cones [1–6]. It has been proposed 
that these molecules, together with SEC1/MUNC18-like 
proteins, mediate axonal growth [7]. SNARE proteins are 
indeed crucial for membrane fusion events. In neurons, 
the t-SNAREs Sytx1 and SNAP25, and the v-SNARE 
VAMP2 (and/or TI-VAMP) form the SNARE complex that 
mediates the fusion of presynaptic vesicles with the plasma 
membrane in axons [8, 9]. Axonal growth and guidance 
are fundamental events required to establish the normal 
patterns of connections in the central and peripheral nervous 
system. Directional axonal growth and extension, together 
with cell migration, call for cytoskeletal reorganization and 
stabilization [10–12], but also for membrane dynamics and 
insertion—processes that mediate the extension of neuronal 
leading edges and growth cones [13]. Indeed, a VAMP1-like 
protein, TI-VAMP, which is insensitive to tetanus neurotoxin 
and several Botulinum toxins [14, 15], plays a major role 
in neurite outgrowth by coordinating membrane trafficking 
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and actin remodeling [1, 3, 9, 16]. One mechanism by 
which TI-VAMP leads to the growth of axons, as well as 
their regulation, was clarified when Sytx1 was shown 
to be necessary for Netrin-1-mediated axonal growth 
and guidance and for neuronal migration through direct 
interaction with the Netrin-1 receptor DCC [17, 18]. This 
interaction promotes the exocytosis of vesicles in axonal 
growth cones and leading edges of migrating cells through 
an atypical SNARE complex that involves TI-VAMP but 
not SNAP25 or VAMP2. Additionally, it has been shown 
that Sema3A-mediated repulsion requires the interaction of 
VAMP2 with Neuropilin 1 (Nrp1) and Plexin A1 (PlexA1), 
two essential components of the Semaphorin 3A (Sema3A) 
receptor [19]. These findings have led to the hypothesis that 
axon guidance involves asymmetric membrane trafficking 
across the growth cone; in particular, a localized increase 
in Ca2+ in response to guidance cues evokes SNARE-
dependent exocytosis to promote attractive turning [5, 20] or 
the clathrin-dependent endocytosis necessary for repulsion 
[21], depending on whether the Ca2+ signal is accompanied 
by Ca2+ release from internal stores [13, 22].
Nerve growth factor (NGF), brain-derived neurotrophic 
factor (BDNF), neurotrophin-3 (NT-3), and neurotrophin-4 
(NT-4) are members of the neurotrophin family of growth 
factors. They are all polypeptides that support the growth, 
differentiation and survival of neurons in the developing 
nervous system and maintain neurons in the mature nervous 
system [23–25]. Neurotrophins bind to a receptor called 
p75NTR and to one of the three tropomyosin-related kinase 
(Trk) receptors. NGF binds to TrkA, BDNF and NT4 to 
TrkB, and NT3 to TrkC. It is the differential expression and 
distribution of these receptors and their ligands that allow 
neurotrophins to exert many different functions [25–27].
Indeed, neurotrophins play an important role in 
regulating various processes, including neural survival, 
development, function, and plasticity [28–30]. Many lines 
of evidence have also demonstrated that neurotrophic 
factors promote both axon and dendrite growth [31–33]. 
The absence of TrkB and TrkC signaling interferes with 
the functional maturation of the presynaptic machinery 
by altering the number of synaptic vesicles or their 
exocytotic/endocytotic cycle or both [34].
Moreover, the original discovery that Trks are 
oncogenes has led to the association of their expression 
with the biology of tumors; their expression and signaling 
cascades are often modified not only in tumors of neural 
origin but also in carcinomas, myelomas, and prostate and 
lymphoid tumors [35, 36].
In previous studies, we demonstrated that the 
t-SNARE protein Sytx1 is involved in DCC/Netrin-1-
dependent chemoattraction [17, 18] and that Sytx1 and 
other SNARE proteins are required for the correct formation 
of motoneuronal tracts in vivo [37]. Those findings, together 
with those of other studies, suggest that the crosstalk 
between SNARE proteins and the receptors that mediate 
guidance and outgrowth could be a general mechanism.
SNARE protein complexes are also overexpressed 
in several cancer subtypes, thereby once again suggesting 
a strong link between cancer and neural development. 
In particular, HER2-enriched breast tumors overexpress 
Sytx1A [38]. Additionally, recent results have revealed 
that blocking Sytx1 function in glioblastoma cells halts 
their growth and that human glioblastoma cells with 
inhibited Sytx1 function give rise to brain tumors that are 
up to eight times smaller than control tumor cells [39].
Here we addressed whether Trk-mediated 
neurotrophin effects on neurite outgrowth require the 
involvement of SNARE proteins. We show that Trk 
receptors interact with Sytx1 and TI-VAMP and that these 
SNARE proteins are necessary for neurotrophins to induce 
neurite outgrowth via exocytosis.
RESULTS
Trk receptors associate with the t-SNARE 
Sytx1A/1B in vitro and in vivo
Neurotrophins bind Trk receptors, thus inducing 
their dimerization and autophosphorylation at multiple 
tyrosine residues and leading to the recruitment of various 
intracellular signaling adaptors and the activation of many 
signaling pathways [27, 40]. We first studied whether Trk 
receptors interact with t-SNARE proteins. To this end, 
we focused on the neurotrophin receptor TrkB because it 
is the most abundant. To look for a possible interaction 
between TrkB and proteins of the exocytotic machinery, 
we performed co-immunoprecipitation analyses in lysates 
from embryonic (E15) and adult mouse brains. When 
TrkB antibodies were used to immunoprecipitate brain 
lysates, a band of approximately 35 kDa was detected 
by Western blot (WB) with the HPC-1 antibody, which 
recognizes Sytx1. Furthermore, in immunoblots of brain 
lysates immunoprecipitated with anti-Sytx1 antibodies, 
TrkB bands of 140 and 90 kDa were identified in adults, 
while a TrkB band of 110 kDa was detected in E15 
extracts (Figure 1A, Supplementary Figure 1). These 
three bands are likely to correspond to differentially 
glycosylated TrkB receptors. To corroborate these 
results, we co-immunoprecipitated HEK293 cells co-
transfected with DNAs encoding for both proteins, namely 
TrkBTM-JX-TK-Y817 (tagged with myc) and Sytx1AEGFP. In 
lysates immunoprecipitated with anti-myc antibodies, 
Sytx1AEGFP was detected by WB using anti-GFP. Pull-
downs with anti-GFP antibodies revealed TrkB protein. 
No co-immunoprecipitation was detected when cells were 
transfected with Sytx1AEGFP or TrkBTM-JX-TK-Y817 DNA 
alone (Figure 1B, Supplementary Figure 1).
Next, we explored whether the TrkA receptor also 
interacts with SNARE proteins. In embryonic DRGs, 
which express high TrkA levels, immunoprecipitation 
of TrkA showed Sytx1 co-association. Similarly, 
immunoprecipitation with anti-Sytx1 antibodies 
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Figure 1: (A) TrkB and Sytx1 immunoprecipitation of E15 forebrain and adult homogenates (100 μg of total protein). TrkB immunoprecipitation 
probed with an anti-Sytx1 antibody (HPC-1) led to co-immunoprecipitation of Sytx1 in both samples. Sytx1 immunoprecipitation caused co-
association of TrkB. The TrkB receptor appeared as three bands, consistent with the highly-glycosylated, glycosylated, and unmodified versions of 
the receptor. For each experiment, three adult brains and pools of E15 embryos of three pregnant mice were used. At least three replicates for each 
sample were used in experiments. (B) Co-immunoprecipitation experiments in HEK293 cells transfected with pSytx1AEGFP alone or together 
with pCMVtag3A-TrkB TM-JX-TK-Y817 tagged with myc. Anti-myc immunoprecipitation resulted in co-association with Sytx1A, visualized with anti-
GFP antibodies (lower panel). The reverse immunoprecipitation with anti-GFP antibodies also revealed TrkB protein in the immunoblots with anti-
myc (upper panel). (C) TrkA and Sytx1 immunoprecipitation of E14 DRG homogenates. TrkA immunoprecipitation probed with an anti-Sytx1 
antibody led to co-immunoprecipitation of Sytx1 (upper panel). Sytx1 immunoprecipitation showed co-association of TrkA (lower panel). (D) Co-
immunoprecipitation experiments in HEK293 cells transfected with Sytx1A-cmv together with TrkA-HA (left panel) and TrkC-myc (right panel). 
Anti-HA and anti-myc immunoprecipitation resulted in co-association with Sytx1A, as visualized with anti-HPC1 antibodies (lower panels). The 
reverse immunoprecipitation with anti-HPC1 antibodies also revealed TrkA and TrkC protein in the immunoblots, as visualized with anti-HA and 
anti-myc antibodies (upper panels). (E) Confocal images of hippocampal growth cones treated with BDNF for 0–30 min, immunolabeled for TrkB 
and Sytx1. Note increased TrkB/Sytx1 co-localization in growth cones incubated with BDNF. An average of thirty growth cones per condition 
from at least three different experiments were quantified. (F) Quantification of TrkB/Sytx1 co-localization signals in hippocampal growth cones 
expressed as Mander’s overlap coefficient, in cultures treated with BDNF or in control conditions. Arrows indicate specific bands. Significant 
differences are labeled by asterisks (*p ≤ 0.05). Scale bar: E, 3 μm. Error bars indicate SEM.
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yielded visualization of the full-length TrkA form by 
immunoblotting (Figure 1C).
As a further step, we performed immunoprecipitation 
experiments in vitro using TrkA and TrkC constructs. We 
co-immunoprecipitated HEK293 cells co-transfected with 
DNAs encoding for both proteins (TrkA-HA or TrkC-
myc with Sytx1A-CMV). In lysates immunoprecipitated 
with anti-HA antibodies, Sytx1A-CMV was detected 
by WB using anti-HPC1. Pull-downs with anti-HPC1 
antibodies revealed TrkA protein (Figure 1D, left panel). 
In lysates immunoprecipitated with anti-myc antibodies, 
Sytx1A was detected by WB using anti-HPC1. Pull-
downs with anti-HPC1 antibodies revealed TrkC protein 
(Figure 1D, right panel). Together, these data indicate that 
Sytx1A co-associates with TrkA, TrkB and TrkC after 
expression in non-neuronal cells.
To determine whether neurotrophins regulate the 
association of TrkB and Sytx1, we incubated hippocampal 
cultures with BDNF and then measured overlapping 
signals in axonal growth cones by immunofluorescence. 
A significant increment in Sytx1/TrkB co-localization 
was detected in these structures after 15 and 30 min of 
treatment with BDNF (Figure 1E, 1F). These data suggest 
that BDNF increases the co-association of TrkB receptor 
and Sytx1 in the growth cones of developing neurons. 
(Figure 1E, 1F).
Interaction with other SNARE proteins
Since Trk receptors interact with Sytx1, we reasoned 
that they might associate with additional SNARE 
proteins. Negative co-immunoprecipitation results were 
observed when TrkB, SNAP25 (pEF-BOS-SNAP25-
FLAG and pEGFPC1-TrkB) (Figure 2A, Supplementary 
Figure 1), and VAMP2 (pEF-BOS-VAMP2-FLAG and 
pEGFPC1-TrkB) (Figure 2B, Supplementary Figure 1) 
were overexpressed in HEK293 cells. To address whether 
the above pattern of interactions was also common to 
other Trk receptors, we studied the interaction between 
TrkA or TrkC and SNARE proteins. Negative co-
immunoprecipitation was observed again when TrkA 
or TrkC were co-transfected with SNAP25 and VAMP2 
(Figure 2C, 2D) in these cells.
To confirm these findings, a series of co-
immunoprecipitation analyses were also performed 
in lysates from embryonic (E15) and adult brains. We 
did not detect co-immunoprecipitation of TrkB with 
either SNAP25 or VAMP2. This observation was then 
confirmed by immunoprecipitating VAMP2 and SNAP25 
and immunoblotting with anti-TrkB (Supplementary 
Figure 2).
As the formation of the SNARE complex involves 
v-SNAREs and t-SNAREs, we next studied the possible 
interaction between the t-SNARE TI-VAMP and the 
Trk receptor. We co-immunoprecipitated HEK293 cells 
cotransfected with DNAs encoding for TrkB-GFP and 
TI-VAMP. In lysates immunoprecipitated with anti-GFP, 
TI-VAMP was identified by WB using anti-TI-VAMP 
(Figure 3A). The reverse immunoprecipitation assay also 
indicated a TI-VAMP/TrkB interaction in transfected cells 
(Figure 3A).
Additionally, we treated hippocampal primary 
cultures with BDNF for 0, 15 and 30 min and analyzed 
the co-localization between TrkB and TI-VAMP. Confocal 
images and intensity correlation analysis indicated an 
increase in the co-localization of both proteins with respect 
to the control (Figure 3B, 3C). Together, these results may 
suggest that TI-VAMP, like Sytx-1, interacts with TrkB 
receptors in a BDNF-dependent manner.
Identification of the protein region responsible 
for Trk/Sytx1 interaction
To identify the domains of TrkB necessary for 
its interaction with Sytx1EGFP, we generated four 
truncated TrkB proteins in the pCMVtag3a-Myc vector. 
There are 10 known conserved tyrosine residues in the 
cytosolic tail of mammalian Trk receptors, [41, 42]. 
The Y670, Y674 and Y675 sites in the TrkA receptor 
are located in the auto-regulatory loop of the tyrosine 
kinase domain and thus modulate kinase activity when 
phosphorylated. Other tyrosines are responsible for 
the interaction with adaptor and scaffold proteins that 
contain phosphotyrosine binding (PTB) domains or 
Src-homology-2 (SH2) domains. The best characterized 
of these docking sites in human TrkA are Y490 and 
Y785. We thus generated the following constructs: the 
tyrosine kinase domain, containing the three tyrosine 
residues of the auto-regulatory loop of TrkB (TrkBTK); 
the transmembrane-juxtamembrane-tyrosine kinase 
domain, carrying the analogous tyrosine 490 (Y490) 
in TrkB receptors (TrkBTM-JX-TK); the juxtamembrane-
tyrosine kinase domain, lacking the transmembrane 
domain (TrkBJX-TK-Y817) but including the Y817 analogous 
to the Y785 of TrkA receptors; and the entire intracellular 
domain, which carries all the phosphorylatable catalytic 
tyrosine residues, which included the transmembrane 
domain (TrkBTM-JX-TK-Y817) (Figure 4A). DNAs were 
expressed in HEK293 cells, and their expression levels 
and predicted molecular weights were measured by 
immunoblot (Figure 4B). TrkB DNA constructs were 
transfected in combination with Sytx1A, and lysates were 
processed for immunoprecipitation and immunoblotting. 
Co-immunoprecipitation with GFP antibodies revealed 
co-association of Sytx1A with all four constructs 
(Figure 4C, right panel). The reverse experiments using 
anti-myc antibodies to immunoprecipitate the TrkB 
fragments confirmed this result (Figure 4C, left panel). 
These findings indicate that the TK fragment is the basic 
region necessary for the interaction with Stx1.
We next attempted to identify the domains of 
Sytx1A required for its interaction with Trk receptors. We 
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generated several truncated Sytx1A constructs to which 
EGFP was fused at the N-terminus region (Cotrufo et al., 
2011). We used six constructs carrying the H3 (Sytx1AH3), 
transmembrane (Sytx1ATM), H3-transmembrane 
(Sytx1AH3TM), and the Habc (Sytx1AHabc) domains, as 
well as the complete cytosolic tail (Sytx1ACYT) and a full-
length construct (Sytx1AFL) (Figure 4D). The predicted 
molecular weights were measured by immunoblot (Figure 
4E). Constructs were transfected in combination with 
pCDNA-TrkA-HA (Figure 4F). Co-transfection with 
either the Sytx1ACYTEGFP, Sytx1AH3 or Sytx1AHabcEGFP 
constructs did not show co-association. In contrast, HA 
antibodies co-immunoprecipitated the Sytx1AH3TMEGFP 
and Sytx1ATMEGFP chimeras (Figure 4F, left panel). 
The reverse experiments, using anti-GFP antibodies to 
immunoprecipitate EGFP-tagged Sytx1A chimeras and 
immunoblotting with anti-HA antibodies, yielded results 
identical to those above (Figure 4F, right panel). Sytx1A 
and TrkB appeared to co-associate through the TM region 
of Sytx1A and the auto-regulatory loop containing the 
tyrosine kinase domain of TrkB.
Botulinum toxin C1 blocks axonal growth of 
Nodose and DRG axons
The sensory neurons of the Nodose ganglia are a 
classic example of peripheral nervous system neurons 
that do not require NGF for survival or outgrowth during 
development. However, they are dependent on BDNF 
and to a lesser extent on NT-3 and NT-4 [43, 44]. In the 
dorsal root ganglion (DRG) and trigeminal ganglia, a large 
population of neurons conveying different modalities 
of sensory information express TrkA, and the viability 
and outgrowth of these cells depends on NGF [45]. 
Nevertheless, other DRG neurons depend on NT-3 and 
TrkC [46, 47]. Therefore, we used Nodose ganglia and 
DRGs as models to study the effect of Sytx1 blockade 
on TrkB-, TrkC- and TrkA-expressing populations, 
respectively. The specific response of these populations 
to BDNF, NT-3 and NGF allowed us to study the effect of 
Botulinum toxins on axonal outgrowth. Botulinum toxins 
are metallo-proteases that markedly reduce the exocytosis 
of synaptic vesicles and neurotransmitter release by 
Figure 2: Co-immunoprecipitation experiments in HEK293 cells transfected with (A) pEF-BOS-SNAP25-FLAG alone or together 
with pEGFPC1-TrkB. (B) pEF-BOS-VAMP2-FLAG alone or together with pEGFPC1-TrkB. (C) pEF-BOS-SNAP25-FLAG, pEF-BOS-
VAMP2-FLAG and TrkA-HA. (D) pEF-BOS-SNAP25-FLAG, pEF-BOS-VAMP2-FLAG and TrkC-myc. No co-immunoprecipitation was 
observed between proteins analyzed with anti α-GFP, anti-myc, anti-FLAG, or anti-HA antibodies. Two transfections in HEK cells per 
condition were run in parallel for each experiment and three experiments were done. Arrows indicate specific bands.
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cleaving specific SNARE proteins [48]. While Botulinum 
Toxin A (BoNT/A) cleaves only SNAP25, Botulinum 
Toxin C1 (BoNT/C1) cleaves both Sytx1 and SNAP25, 
and Clostridium tetanus toxin (TeNT) cleaves VAMP2 
[49, 50].
Nodose (Figure 5A–5D) and DRG (Figure 5E–5L) 
explants cultured in collagen gels were supplemented 
with BDNF, NGF and NT-3 (all 50 ng/ml). Explants were 
cultured for 1 day in the presence of 15 nM BoNT/C1, 
25 nM BoNT/A or 2nM TeNT, and axonal growth in the 
presence and absence of toxins was compared. Nodose and 
DRG explants, incubated with BDNF or NGF respectively, 
did not show a significant decrease in axonal growth when 
cultured with BoNT/A or TeNT (Figure 5B, 5F, 5J, 5D, 5H 
and 5L). On the other hand, those treated with BoNT/C1 
showed high inhibition of axonal growth (BDNF, NGF) 
(Figure 5C, 5G and 5K, 5M, 5N). A similar scenario 
was observed when DRG explants were incubated with 
NT3, in which case a statistically significant decrease 
was also observed in explants incubated with BonT/C1 
but not with BonT/A and TeNT (Figure 5I–5L). Finally, 
we counted the number of pyknotic nuclei present 
in Nodose ganglia incubated with toxins. Treatment 
with BoNT/C1, BoNT/A and TeNT did not result in an 
increased number of pyknotic cells, thereby indicating 
that in our experimental conditions Botulinum toxins 
did not lead to neuronal cell death (Figure 5P). We thus 
conclude that cleavage of Sytx1, but not of SNAP25 or 
VAMP2, inhibits neurotrophin-dependent axonal growth. 
This finding, together with the observation of a specific 
interaction between Trk receptors and Sytx1, suggests that 
this SNARE protein is required for neurotrophin-mediated 
neurite extension and outgrowth.
To corroborate these data, we next used dissociated 
primary Nodose cultures supplemented with BDNF 
and treated them with BoNT/C1, BoNT/A and TeNT 
(Figure 6). Individual neurite length was measured. A 
significant decrease in this parameter was found only in 
cultures incubated with BoNT/C1 (Figure 6E).
Neurons require Sytx1 and TI-VAMP for BDNF-
dependent outgrowth
To further substantiate the notion that the TrkB- 
Sytx1 interaction is required for BDNF-dependent axonal 
growth, we generated a Sytx1AH3TM construct containing 
the minimal Sytx1A interaction domain, as a dominant 
negative to interfere with Sytx1 (Cotrufo et al., 2011). We 
cloned Sytx1AH3TM into a pIRES-EGFP vector (Clontech) 
to generate a unique transcript capable of translating 
Figure 3: (A) Co-immunoprecipitation experiments in HEK293 cells transfected with TrkB-GFP and TI-VAMP showing an in vitro 
interaction. Two transfections in HEK cells per condition were run in parallel for each experiment and three experiments were done. (B) 
Confocal images of hippocampal growth cones treated with BDNF for 0–30 min, immunolabeled for TrkB and TI-VAMP. Note increased 
TrkB/TI-VAMP co-localization in growth cones incubated with BDNF. (C) Quantification of TrkB/ TI-VAMP co-localization signals in 
hippocampal growth cones expressed as Mander’s overlap coefficient, in cultures treated with BDNF or in control conditions. An average 
of twenty growth cones per condition were quantified in four experiments using different cell cultures. Significant differences are labeled 
by asterisks (*p ≤ 0.05; ***p ≤ 0.001). Scale bar: B, 3 μm. Error bars indicate SEM.
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Figure 4: Characterization of protein regions required for Sytx1A/DCC interaction (A) Diagram summarizing TrkB domains and the 
truncated TrkB-myc chimeras generated. (B) Western blot for TrkB fragments: expression of the truncated TrkB-myc DNAs in HEK293 
cells, showing that they generate proteins of the appropriate molecular weight, between 24 and 50 kDa, as revealed by immunoblotting 
with anti-myc antibodies (C) Myc antibodies co-immunoprecipitated Sytx1-GFP (left panel, arrow). The reverse experiments, using anti-
GFP antibodies to immunoprecipitate Sytx1A, and immunoblotting with anti-myc antibodies yielded identical results as above (right 
panel, arrows). (D) Diagram summarizing Sytx1A domains and the truncated Sytx1AEGFP chimeras generated. (E) Expression of the 
several Sytx1AEGFP DNAs in HEK293 cells, showing that they generate proteins of the appropriate molecular weight, between 65 and 
27 kDa, as revealed by immunoblotting with anti-GFP antibodies. (F) Western blot analysis of transfected cell with Sytx1 constructs and 
TrkA-HA. Co-transfection with either the Sytx1ACYTEGFP or the Sytx1AHabcEGFP constructs did not reveal co-association. In contrast, 
HA antibodies co-immunoprecipitated the Sytx1AH3TMEGFP (right panel, upper). The reverse experiments, using anti-GFP antibodies to 
immunoprecipitate EGFP-tagged Sytx1A chimeras, and immunoblotting with anti-HA antibodies gave identical results as above (left panel, 
bottom). Arrows indicate specific bands.
Oncotarget8www.oncotarget.com
both target and EGFP proteins. We also took advantage 
of two shRNAs for TI-VAMP (D06 and D07) and two 
shRNAs for Sytx1A (shRNA1 and shRNA2). The shRNA 
sequences were tested in transfected cells to assess the 
percentage of silencing. D06 TI-VAMP shRNA induced a 
50% decrease in expression while D07 TI-VAMP shRNA 
achieved about 85% (Supplementary Figure 3). Nodose 
primary cultures were then electroporated with control 
pIRES-EGFP (Figure 7A), pIRES-Sytx1AH3TMEGFP 
(Figure 7C), TI-VAMP (Figure 7D, 7E), Sytx1 shRNAs 
Figure 5: Confocal images of Nodose and DRG explants co-cultured in collagen gel. Explants were immunolabeled for 
βIII-Tubulin and counterstained with fluorescent anti-mouse 488. Explants were co-cultured with BDNF (A–D), NGF (E–H) and NT3 
(I–L). In each row, explants were treated with BoNT/A, BoNT/C1 and TeNT. Bar graph expressing the area of neurites in Nodose explants 
supplemented with BDNF (M) and in DRG explants supplemented with, NGF (N) and NT-3 (O), and treated with BoNT/A, BoNT/C1 
and TeNT. Bar graph showing the number of cells with pycnotic nuclei, indicating that toxin treatment did not affect neuronal death (P). 
N indicates the number of explants obtained from different animals in different experiments. Nodose explants came from five experiments 
in which at least three embryos per condition were used. DRG explants were obtained from six experiments in which one embryo per 
condition was used. Significant differences are labeled by asterisks (*p ≤ 0.05; **p ≤ 0.01). Scale bar: A, 300 μm. Error bars indicate SEM.
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(Figure 7F), and a scrambled shRNA sequence (SCR) 
(Figure 7B). Finally, we treated the cultures with BDNF 
(50 ng/ml) for one day. We then labeled them with βIII-
Tubulin and anti-GFP antibodies (Figure 7). Interfering 
with Sytx1A or TI-VAMP siRNA caused a significant 
reduction in axonal length with respect to control 
(scrambled and EGFP) electroporations. Moreover, 
electroporation with Sytx1AH3TMEGFP markedly 
reduced this parameter (about 95%). Together, these 
findings indicate that interference with Sytx1 function 
via expression of a Sytx1AH3TM dominant negative or 
using siRNAs blocks BDNF-mediated axonal growth in 
dissociated neurons (Figure 7G).
BDNF-mediated exocytosis in Nodose growth 
cones
The results presented here point to a biochemical 
and functional link between Trk receptors and the proteins 
involved in exocytotic machinery. Additional studies were 
done to corroborate this hypothesis. Bodipy-ceramide has 
been used to study vesicle formation and exocytosis in 
non-neuronal and neuronal cells [40, 51]. Bodipy-ceramide 
has a concentration-dependent emission spectrum, with 
a maximum at 515 nm (green) at low concentration. In 
the growth cone, green label was evident in the plasma 
membrane, extending into the filopodia and lamellipodia. 
At high concentration, Bodipy-ceramide formed excimers 
with an emission maximum at 620 nm (red). These features 
allow selective visualization of Golgi-derived vesicles 
(those secreted during exocytosis). The presence of 
Bodipy-ceramide labeling along neurites was also evident 
as dot-like structures that accumulated at growth cones. As 
suggested by Huber and colleagues, it is likely that the dots 
represent exocytic vesicles in transit to neuritic tips, where 
new membrane addition takes place [52].
To study whether BDNF/TrkB regulates exocytosis 
in a SNARE-dependent manner, we pulse-labeled Nodose 
explants with Bodipy-ceramide at room temperature 
and then chased them for 2.5–3 h at 37°C. Hence, all 
Figure 6: Examples of Nodose primary cultures supplemented with BDNF (A) and treated with BoNT/A (B), BoNT/C1 (C) and TeNT 
(D–E) Bar graph showing the quantification of neurite length when treated with neurotoxins compared with control. Significant differences 
are labeled by asterisks (**p ≤ 0.01). An average of thirty neurons per condition were quantified in five separate experiments. Scale bar: A, 
50 μm. Error bars indicate SEM.
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membrane addition experiments were recorded in the green 
(cytoplasmatic membrane) and red channels (exocytosis 
vesicles). The results of these pulse–chase experiments 
revealed an initial accumulation of Bodipy-ceramide 
label (red channel) in the Golgi apparatus, followed by 
the sequential appearance of vesicle-like structures in the 
cell body, neurites, and growth cones (Figure 8A–8C). 
We quantified the average pixel ratio (red/green), which 
gave a direct measurement of the red spots at the growth 
cones (Figure 8D). Incubation with BDNF led to a marked 
reduction of Bodipy-ceramide fluorescence between 
15 and 30 min, thereby indicating depletion and release 
of pre-labeled vesicles (Figure 8B, 8D). Conversely, 
BDNF and BoNT/C1 treatment showed a constant level 
of fluorescence over time, indicating the inhibition of 
exocytosis (Figure 8C, 8D).
In order to corroborate that VAMP2 and SNAP25 
were not involved in this mechanism, we stimulated Nodose 
neurons with BDNF and simultaneously treated them with 
BoNT/A and TeNT. As in BDNF treatment, fluorescence 
decreased at 15 and 30 min, thereby demonstrating the 
fusion of exocytotic vesicles at the membrane (Figure 8D).
These results indicate that Sytx1 cleavage abolishes 
the exocytosis of pre-labeled vesicles and demonstrate that 
Sytx1 is required for BDNF-regulated exocytosis in the 
growth cone.
DISCUSSION
Axonal growth is a complex event in which the 
mechanisms that regulate elongation, fasciculation and 
guidance are closely coordinated. During pathfinding, 
growth cones exhibit a variety of behaviors, such as cone 
collapse, repulsion and attraction [53–58]. Such activities 
involve cytoskeletal re-arrangements and plasmalemma 
re-modeling [4, 10, 13, 59]. In this context, neurotrophins 
play an important role as trophic molecules, regulating 
cell death and proliferation [23, 32, 60], as well as neurite 
extension and axonal guidance [31, 32]. The activation 
of neurotrophin receptor Trk has been shown to result 
in the induction/triggering of several signaling pathways 
that play instructive roles in cytoskeleton regulation [61], 
membrane expansion [62], gene transcription [63, 64], and 
protein translation [65, 66].
Figure 7: Examples of electroporated Nodose primary cultures supplemented with BDNF. Cells were electroporated with (A) GFP, (B) 
scrambled shRNA, (C) SytxH3TMEGFP, (D) TI-VAMP shRNAD06, (E) TI-VAMP shRNAD07, and (F) Sytx1A shRNA1. Cells were 
immunolabeled for βIII-Tubulin followed with secondary anti-mouse coupled to alexafluor 568 and counterstained with anti-GFP followed 
by fluorescent anti-rabbit 488. (G) Bar graph representing the percentage of transfected axonal length normalized to the control condition. An 
average of eighty neurons per condition were quantified in four experiments using different cell cultures. Significant differences are labeled 
by asterisks (*p ≤ 0.05; ***p ≤ 0.001), (n indicates the number of neurons analyzed per condition). Scale bar A, 50. Error bars indicate SEM.
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The addition of new membrane to nerve processes 
is an essential step in nerve growth and differentiation 
and also in axonal guidance [13, 67, 68]. We have already 
described that Netrin-1 receptor DCC interacts with Sytx1 
in a Netrin-1-dependent manner to exert chemoattraction 
and to guide axons and migrating neurons toward their 
final destination [17, 18]. In the present study, we 
addressed whether other key secreted molecules, namely 
neurotrophins, also require SNARE proteins to exert 
their functions during development. To this end, we first 
focused on the interaction between neurotrophin receptors 
with classical SNARE complex proteins. As the TrkB 
receptor is the most widely expressed receptor in the 
CNS, we examined whether TrkB and Sytx1 interact in 
adult and embryonic forebrains. We demonstrated that 
TrkB receptors interact in vivo and in vitro with Sytx1, 
but not with VAMP2 or SNAP25. Furthermore, co-
immunoprecipitation assays in vitro revealed that TrkA 
and TrkC also interact with Sytx1, thereby supporting the 
notion of a common relationship between Trk receptors 
and the proteins regulating exocytosis. The interaction 
of Trk receptors with Sytx1 was confirmed by co-
immunoprecipitation assays using specific domains of 
these proteins. Our results also suggest that this interaction 
is regulated by Trk ligands, since BDNF treatment of 
hippocampal growth cones increased TrkB/Sytx1 co-
localization. Thus, together with our previous findings on 
the Netrin-1 receptor [17, 18] and other studies reporting 
interactions of other guidance receptors with SNARE 
proteins [13, 69, 70], our findings support the notion of a 
common mechanism for receptors that regulate guidance 
and neurite extension. In this mechanism, the receptors 
are coupled to SNARE proteins in order to mediate the 
guidance and outgrowth roles of the former, thereby 
revealing a tight regulation of exocytosis by the activation 
of guidance receptors [71]. However, we cannot exclude 
that Sytx1 exerts a different role in neurotrophin signaling, 
since in unstimulated conditions the degree of TrkB/Sytx1 
co-localization was relatively high. We found that Trk 
receptors did not co-associate with SNAP25 or VAMP2. 
Previous experiments showed that SNAP25 is essential for 
evoked synaptic transmission, but not for nerve growth 
or stimulus-independent neurotransmitter release [72]. 
In addition, in SNAP25 null mutants, SNAP24 exerts its 
function in neurotransmitter release [73]. With regard to 
VAMP2, cleavage of VAMP2 by TeNT or BoNT/B has 
no effect on neurite extension or synaptogenesis [74]. 
Similar results were found in VAMP2 KO mice [75]. 
VAMP2 may function by catalyzing fusion reactions and 
stabilizing fusion intermediates; however, it is not required 
for synaptic fusion [75].
Exocytosis requires at least one v-SNARE protein, 
in addition to Sytx1. In previous work, we found that 
DCC receptors interact with TI-VAMP in a Netrin-
dependent manner to induce exocytosis in growth cones 
[18]. Therefore, here we studied the interaction between 
Trk receptors and TI-VAMP protein and its dependence on 
BDNF. Trk receptors interacted with the developmentally 
regulated and growth cone-enriched v-SNARE TI-VAMP. 
We used clostridial neurotoxins to examine the function 
of SNARE proteins, as the former cleave the latter in a 
specific way [48–50], and peripheral ganglia as a model 
to study the different neurotrophin-dependent neuronal 
populations. Our results showed that, in Nodose and 
DRG explants and in primary cultures, the cleavage of 
Sytx1 by BoNT/C1 decreases BDNF-, NGF- and NT3-
dependent axonal growth (Figures 5, 6). In contrast, 
cleavage of SNAP25 and VAMP2 by BoNT/A and 
TeNT did not affect NGF-dependent or NT3-dependent 
axonal growth. These results indicate that Sytx1, but 
not SNAP25 or VAMP2, is important for neurotrophin-
mediated axonal growth. These results are in agreement 
with the above co-immunoprecipitation experiments, 
which demonstrated the interaction of Trk receptors with 
Sytx1, but not with SNAP25 or VAMP2. On the other 
hand, we found that BoNT/C1 treatment of dissociated 
Nodose neurons resulted in a decrease in neurite length. 
These results were confirmed by experiments using the 
Sytx1-H3TM fragment (as a Sytx1 negative dominant), as 
well as siRNA downregulation strategies. Sytx1 and TI-
VAMP downregulation, as well as the expression of the 
Sytx1-H3TM dominant negative, dramatically reduced 
neurite length in ganglia and hippocampal neurons treated 
with BDNF. These findings support the hypothesis that 
the interaction between TrkB and Sytx1 is necessary for 
BDNF-mediated axonal growth and that a functional TI-
VAMP/Sytx1 complex is required for BDNF-mediated 
axonal growth during development.
The previous results point to a biochemical and 
functional link between the receptors for trophic factors 
and the proteins that regulate exocytosis. We demonstrate 
that treatment with BoNT/C1 reduces axonal elongation 
in Nodose and DRG explants, as a result of the cleavage 
of Sytx1. Finally, we sought to address how SNARE 
proteins allow the elongation of neuronal axons by an 
exocytotic process. To this end, we used Bodipy-ceramide 
to explore exocytosis induction during BDNF-dependent 
axonal growth in Nodose explants. Incubation with BDNF 
led to the release of pre-labeled vesicles at the cone 
tips (Figure 8). Additionally, treatment with BoNT/C1 
indicated that Sytx1 cleavage abolished the decrease in 
fluorescence and therefore the exocytosis of pre-labeled 
vesicles (Figure 8). Nevertheless, treatments with BoNT/A 
and TeNT did not change the rate of exocytosis. These 
results suggest that Sytx1 is required for BDNF-regulated 
exocytosis in growth cones.
Our results might also explain why Sytx1 is 
an absolute requirement for neuronal survival and 
maintenance [76]. Recent articles outline the importance 
of Sytx1 in these processes [42]. Although Syntaxin 
relevance has been ascribed to a lack of trophic supply 
by glia, the growth of Sytx1A/1B double knock-out 
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hippocampal neurons on wild-type astrocytes still impaired 
their survival, thereby indicating a cell-autonomous effect. 
The present study, showing a Sytx1-dependent regulation 
of Trk receptor function, could fill this gap.
In conclusion, our results demonstrate that 
neurotrophin/Trk receptor signaling requires two SNARE 
proteins, namely Sytx1 and TI-VAMP, to mediate axonal 
outgrowth and extension. Together with previous 
studies showing that various SNARE complex proteins 
are necessary for the signaling of guidance molecules 
exerting either chemoattraction (e.g. Netrin1, [17, 18]) 
or chemorepulsion (e.g., class III Semaphorins, [70]; 
Slits/Robo [77], our findings on neurotrophins—another 
family of extracellular factors that mediates axonal 
growth—support the notion that the association of 
receptor complexes with specific sets of SNARE proteins 
that mediate exocytosis or endocytosis is a general 
mechanism by which neurotrophic factors and guidance 
cues exert their effects to promote axonal guidance and 
growth.
Figure 8: Fluorescence micrographs of the Nodose explant axonal growth cones. Neurons were labeled with Bodipy-ceramide. 
Growth cones were challenged with control medium (A), BDNF (B), after factor deprivation, or BDNF+BoNT/C1 (C), for the time 
indicated in minutes. Percentage of average intensity of red fluorescent puncta in growth cones for control, BDNF-, BoNT/C1-, BoNT/A- 
and TeNT-treated Nodose neurons (normalized to 100% at the onset of treatment) (D). Data points are means ± s.e.m. from eighty growth 
cones quantified from an average of eighteen explants per condition taken from six embryos in three separate experiments. Significant 




OF1 embryos and adult mice (Charles River 
Laboratories, France) were used. The mating day was 
considered embryonic day 0. Pregnant females at the 
development stage of interest were killed by cervical 
dislocation, following the European Community Council 
directive and the National Institutes of Health guidelines 
for the care and use of laboratory animals. Experiments 
were also approved by the local ethics committees.
Neuronal primary culture
E16 mouse brains were dissected out to obtain 
hippocampal neuronal cultures in PBS containing 0.6% 
glucose. The brains were then dissociated by incubation 
for 12 min at 37ºC with 0.05% trypsin (Invitrogen) and 
treated for 10 min with DNase (Roche Diagnostics); tissue 
pieces were dissociated by gentle sweeping. Cells were 
then counted and seeded at a density of 50,000 neurons 
per dish in 4-well plates on coverslips pre-coated with 
poly-D lysine (Sigma) for immunocytochemistry and at a 
density of 3 million neurons per well in 6-well plates and 
107 cells in 90-mm plates for biochemical analysis. Cells 
were cultured for 3 days in Neurobasal medium containing 
1% glutamax and 2% B27 supplement. Primary cultures 
were incubated with BDNF for 0, 15, and 30 min (50 ng/
ml, Promega).
For Nodose primary cultures, E14 mouse embryos 
were dissected in F12 media (Gibco-BRL). Ganglia 
were dissociated for 10 min at 37ºC with 0.05% trypsin 
(Invitrogen), and the tissue pieces were dissociated by 
gentle sweeping. Cells were then counted and seeded 
at a density of 5,000 neurons per dish in 4-well plates 
on coverslips pre-coated with polyornithine (Sigma, 
0.5% overnight) and laminin (20 ug/ml for 2 h) for 
immunocytochemistry. The neurons were incubated 
for 24 h in a defined media containing Dulbecco’s 
Modified Eagle’s Medium (DMEM, Gibco-BRL), 
10% Fetal Bovine Serum (FBS), 0.54% glucose, 1% 
glutamine, 1% Penicillin/ streptomycin, N2 and B27, 
and supplemented with 50 ng/ml BDNF (Promega). The 
day after, primary cultures were deprived for 2 h and 
then treated with 100 ng BDNF or control medium for 
0, 5, 15 and 30 min.
Explant cultures
Hippocampal explants were obtained from E15 
brains, sectioned using a tissue chopper. Small tissue 
explants (300–400 µm thick) were obtained from the 
CA1/CA3 regions [78]. Hippocampal explants were 
cultured in Neurobasal medium (Gibco-BRL) plus 
0.54% glucose, 0.032% NaH2CO3, L-glutamine, 
and 10% Horse Serum and supplemented with B27. 
Nodose and DRG explants (E14), obtained as above, 
were embedded in collagen gels for 1 day or cultured 
on polyornithine-laminin dishes in DMEM (Gibco-
BRL) plus medium supplemented with 0.54% glucose, 
0.032% NaH2CO3, L-glutamine, B27, N2 and BDNF 
(50 ng/ml, Promega), and NT3 (50 ng/ml, PreproTech) 
or NGF (50 ng/ml, Sigma). Explant cultures were 
treated with 25 nM BoNT/A (Metabiologics, INC), 
15 nM BoNT/C1 (Metabiologics, INC) or 2 nM TeNT 
(Sigma) for 24 h.
Bodipy labeling
Nodose explants were incubated on day 2 and 
day 3 respectively, with the Bodipy-labeled-ceramide–
BSA complex (Invitrogen). To allow internalization and 
accumulation of the labeled lipid complex in the Golgi 
apparatus, explants were incubated for 30 min at 37ºC in 
their own medium and washed 5 times. To allow transport 
to the cell surface, they were further incubated at 37ºC 
for 2 or 3 h [51, 79]. The nodose explants were then time-
course treated with BDNF for 0, 15 and 30 min. After the 
treatment, they were fixed with 4% paraformaldehyde and 
0.5% glutaraldehyde/PBS 0.1M for 30 min and washed 
with PBS 0.1M several times before the coverslips were 
mounted with Mowiol. The binding of Bodipy to cells was 
monitored with single-line excitation at 543 nm and 488 
nm using a TCS SP2 confocal microscope.
Bodipy quantification
Quantitative analysis of the confocal images of 
growth cones was performed by measuring the average 
pixel intensity of each image with an ImageJ macro. 
The macro transformed all the images (red and green) 
into a 32-bit depth and then ran a threshold between 10 
to 255 gray levels to avoid background from 0 to 10 
gray levels. Finally, we measured the area and the mean 
gray value for each channel. The average pixel intensity 
was then calculated from this value on the basis of the 
ratio between red and green channels. The values were 
classified in function of the treatment time. At least 5 
separate experiments (usually 7–8) were carried out for 
each condition. The number of axonal growth cones 
counted is shown in the figure legends.
HEK 293T culture and transfection
HEK293 cells were cultured in DMEM, 10% FBS, 
0.5% glutamine and 1% penicillin/ streptomycin. All cells 
were maintained in 5% CO2 at 37ºC. For transfection, 
cells were cultured overnight to 60–70% confluence in 
90-mm culture plates. The transfection was performed in 
Opti-MEM medium with Lipofectamine Reagent Plus, 
following the manufacturer’s instructions (Invitrogen, 
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Carlsbad, CA). Cells were transfected with different 
combinations of cDNAs: pEF-BOS-SNAP25-FLAG 
and pEF-BOS-VAMP2-FLAG (kindly provided by Dr. 
M. Fukuda, RIKEN, Japan); TI-VAMP (TrueClone, 
Origene); pcDNA-TrkA-HA (kindly provided by Dr. D. 
Martin-Zanca); pEGFPc1-TrkB (kindly provided by Dr. 
RA Segal, Harvard Medical School, USA); and pcDNA-
TrkC-myc (kindly provided by Dr. RA Barker, Montreal 
Neurological Institute, Canada); pCMVtag3a-TM-JX-TK-
Y817-TrkB (TrkBTM-JX-TK-Y817); pCMVtag3a-TM-JX-TK-
TrkB (TrkBTM-JX-TK); pCMVtag3a-JX-TK-TrkB (TrkBJX-
TK-Y817); and pCMVtag3a-TK-TrkB (TrkBTK).
The TrkB truncated fragments were obtained by PCR 
amplification of pEGFPc1-TrkB using specific primers 
and subsequently cloned into EcoRI/HindIII sites in the 
pCMVtag3a expression vector (Clontech). The TrkBTM-
JX-TK-Y817 fragment was obtained by PCR amplification 
of pEGFPc1-TrkB using the following primers: 
Forward 5′TATATGAATTCTATGCATCTCTCGGTCT 
ATGCT3′ and Backward 5′ATATATAAGCTTCTAGCC 
TAGGATGTCCAGGTA3′). The TrkBTM-JX-TK fragment was 
obtained by PCR amplification of pEGFPc1-TrkB using 
the following primers: Forward 5′TATATGAATTCTATG 
CATCTCTCGGTCTATGCT3′ and Backward 5′ATAT 
ATAAGCTTCTACGCCTTCGCCAAGTTCTG3′. The 
TrkBJX-TK-y817 fragment was obtained by PCR 
amplification of pEGFPc1-TrkB using the following 
primers: Forward 5′TATATGAATTCTATGAAGTTGGC 
GAGACATTCC3′ and Backward 5′ATATATAAGCTTCTA 
GCCTAGGATGTCCAGGTA3′. Finally, the TrkBTK fragment 
was obtained by PCR amplification of pEGFPc1-TrkB using 
the following primers: Forward 5′TATATGAATTCTAT 
GCACAACATCGTTCTGAAG3′ and Backward 5′ATAT 
ATAAGCTTCTACGCCTTCGCCAAGTTCTG3′.
Full-length Sytx1A or truncated DNAs (Sytx1 
ACYT, Sytx1AHabc, Sytx1AH3TM, Sytx1AH3, and 
Sytx1ATM) were cloned into EcoRI sites in pEGFPC1 
fusion mammalian protein expression vector (Clontech), 
as described [18]. 
Primary culture and explant transfection
Using the NeonTM transfection system (Invitrogen), 
nodose-dissociated primary cultures were transfected with 
one of the following DNAs: pEGFPC1, Sytx1AH3TMEGFP, 
shRNA TI-VAMP D06 (5′CCGGGCACTTCCTTATGC 
TATGAATCTCGAGATTCATAGCATAAGGAAGTGCTTT 
TTG3′, MISSION iRNA, Sigma) (TI-VAMP shRNAD06) 
and shRNA TI-VAMP D07 (5′CCGGCTTACTCACATGG 
CAATTATTCTCGAGAATAATTGCCATGTGAGTAAGTT 
TTTG3′, MISSION iRNA, Sigma) (TI-VAMP shRNAD07). 
For Sytx1 RNAi experiments, we used a pSUPER.retro.
puro plasmid (OligoEngine, Seattle, WA, USA) and specific 
oligonucleotides of the Sytx1A sequence: 5′GATCCC 
CCCAAGAAGGCCGTCAAGTATTCAAGAGATACTTGA 
CGGCCTTCTTGGTTTTT3′ (Forward), and 5′AGCTAA 
AAACCAAGAAGGCCGTCAAGTATCTCTTGAATACT 
TGACGGCCTTCTTGGGGG3′ (Reverse) [17] (Sytx1Ash 
RNA1) and a shRNA Sytx-1 (5′CCGGGAAAGCCATCGAGC 
AAGGAATCTCGAGATTCCTTGCTCGATGGCTTTCTTTT 
TG3′), MISSION iRNA, Sigma) (Sytx1AshRNA2).
The cells and explants were washed twice with 
PBS 0.1M and then electroporated with two pulses of 
1200V for 20 sec, followed by three pulses of 500V for 
30 sec. The explants were then plated in collagen, while 
the primary culture was plated in polyornithine-laminin 
pre-coated coverslips at a cell density of 5,000, both in 
DMEM plus medium supplemented with 0.54% glucose, 
0.032% NaH2CO3, L-glutamine, B27, N2 and BDNF (50 
ng/ml, Promega).
Immunoprecipitation assays and immunoblots
Embryonic and adult brains, as well as transiently 
transfected HEK293 cells and primary cultures, were 
collected in hypotonic lysis buffer (10 mM KCl, 15 mM 
MgCl2, 10 mM Tris pH 7.2, 5 mM Na4H2PO4, 1% 
Triton X-100, 10 µg/ml Leupeptin, 10 µg/ml Aprotinin, 
1 mM PMSF) containing a protease inhibitor cocktail 
(Roche). Thereafter, cells were centrifuged at 13,000 
rpm for 20 min, and the pellet was discarded. The 
supernatant was analyzed by Western blot or subjected to 
immunoprecipitation. For tissue extracts, samples were 
weighed and 3 volumes of lysis buffer was added. The 
mixture was processed using a Polytron homogenizer, 
and insoluble material was removed by centrifugation at 
13,000rpm for 20 min.
Protein concentration was determined by means of 
the Bradford assay. For the immunoprecipitation assays, 
200–400 µg of total protein per sample was used. Brain 
lysate homogenates were incubated overnight at 4ºC with 
anti-TrkB (1:500; Upstate), anti-Sytx1 (HPC-1 clone 
1:500-1000; Sigma), anti-SNAP25 (SMI-81 clone 1:500; 
Sternberger Meyer), or anti-VAMP2 (1:500; Synaptic 
Systems) in IP buffer (10 mM Tris pH 7, 140 mM NaCl, 
1.5 mM EDTA). Transfected HEK293 cell homogenates 
were incubated with anti-FLAG (1:1000; Sigma), anti-
myc (1:1000; Roche), anti-HA (1:500, Roche), anti-GFP 
(1:1000; Molecular Probes), or anti-TI-VAMP (1:200 
Abcam) antibodies. All the assays were performed 
using Protein G-sepharose beads (Sigma) for 2 h at 4ºC. 
After three washes, 1 volume of 3x Lamelli loading 
buffer (75 mM pH 6.5, 0.5 mM β-mercaptoethanol, 
0.5% SDS, 10% glycerol, and 0.000125% bromophenol 
blue)/SDS-sample buffer was added to the beads, 
and the proteins were analyzed by SDS-PAGE and 
Western blot. Samples were run in polyacrylamide gel 
at the opportune concentration at 120V. Afterwards, 
proteins were transferred onto nitrocellulose membranes 
overnight at 135 mA at 4ºC. The membranes were 
blocked with 5% non-fat dry milk in Tris-HCl-buffered 
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saline (TBS) containing 0.1% Tween 20, and incubated 
overnight at 4ºC with anti-TrkB (1:1000, Upstate), anti-
Sytx1 (HPC-1 clone 1:500-1000, Sigma), anti-SNAP25 
(SMI-81 clone 1:500 Sternberger Meyer), anti-VAMP2 
(1:500, Synaptic Systems), mouse anti-TI-VAMP (1:200 
Abcam), rabbit anti-GFP (1:2000, Invitrogen), mouse 
anti-FLAG (1:1000, Sigma), mouse anti-HA (1:1000, 
Roche), or mouse anti-myc (1:1000, Roche) antibodies. 
After incubation with secondary antibodies, blots were 
developed following the ECL method (Amersham 
Pharmacia Biotech).
To normalize the data, we represented the ratios 
between the amount of co-immunoprecipitated protein 
(e.g., TrkB) and the immunoprecipitating protein (Sytx1) 
(expressed as percentage association with respect to 
controls).
Immunocytochemistry
Nodose explants, DRG explants, and primary 
cultures were fixed with paraformaldehyde 4% PBS 
0.1M (pH 7.4) for 30 min and washed with PBS 0.1M 
several times. The cultures were then permeabilized 
and blocked for 3 h with PBS, Normal Goat Serum 
2% and Triton X-100 0.1% (Sigma). Finally, they were 
incubated overnight at 4ºC with primary antibody 
against neuron-specific class βIIITubulin (clone TUJ-1, 
1:4000; Covance), rabbit anti-GFP (1:500, Invitrogen), 
mouse anti-Sytx1 (1:500), rabbit anti-TrkB (1:500, 
Upstate), or TI-VAMP (1:250, Abcam), followed by 
incubation with Alexa-fluor 488- and Alexa-fluor 
568-coupled corresponding secondary antibodies 
(1:500) and DAPI (Sigma) for 2 h at room temperature. 
The coverslips were then washed and mounted on glass 
slides with Mowiol.
Quantification of explants
The images were captured by an E1000 
fluorescence microscope from Nikon, using a 4X0.13NA 
and 10X 0.30 NA lens. Metamorph software and a 
CoolSnap fix scientific CCD camera were used for 
acquisition. Explants treated with toxins were quantified 
using Image J by calculating the area in pixels occupied 
by the axons. A background pixel level was defined 
and used to subtract the former value, and upper and 
lower density limits were defined for each explant. 
Once the segmentation range was defined, any pixels 
falling within this range were automatically counted. 
To quantify the area occupied by neurites emanating 
from explants, the tissue explant was manually drawn 
and excluded from the picture, thereby giving an area 
measurement for the pixels occupied by the neurites 
alone. The values obtained were plotted on a bar chart 
with their standard deviation. Data were collected from 
at least three independent experiments (3–7 experiments 
per condition). The number of cultures quantified is 
shown in the Figures.
Quantification of immunocytochemistry 
experiments
Confocal images of axonal growth cones (defined as 
the terminal portion of the axons, having a triangular shape 
and being notably thicker than the shaft of the axon) were 
taken with a Leica TCS SPE (Leica Microsystems GmbH, 
Manheim, Germany) confocal scanning microscope 
adapted to an upright LEICA DM 2500 microscope. 
Samples were scanned using 40x 1.15 NA and 63x 1.3NA 
oil objectives. We used a zoom ranging from 1 to 3.5 to 
analyze intracellular regions and the LAS AF software 
from Leica.
Fluorescent images were processed using open 
software Image J. PDM images ((red intensity-mean red 
intensity)×(green intensity-mean green intensity)) were 
calculated and normalized for each pixel of an image and 
expressed as the degree of co-localization of two signals, 
with a value varying from –1 to +1, where –1 indicates 
maximal exclusion, negative values asynchronous 
localization, positive values synchronous localization 
(or co-localization), and +1 maximal co-localization. 
PDM images and Mander’s overlap coefficients were 
calculated using ImageJ “Intensity Correlation Analysis 
plug-in” [80].
Quantification of Nodose primary cultures
The entire images of coverslips were detected by an 
automated inverted fluorescence wide-field microscope 
with high content screening ScanR from Olympus IX81 
using a 20x objective lens and a Hamamatsu Orca-ER 
digital camera (12bit acquisition, 1344*1024 pixels 
chip, and 6.45 μm/pixel). All the captured images were 
used to run an ImageJ plug-in “Stitch grid of images” 
and obtain a single mosaic image for each coverslip. 
The total image of the coverslips was used to calculate 
the total length of each axon, while the Neuron J plug-
in was used to calculate ramification. The total length 
of each experimental group was normalized to control 
conditions.
Statistics
Data were expressed as means ± SEM and were 
analyzed using the Kruskal-Wallis test, followed by the 
Bonferroni Post-hoc test (Statgraphics Centurion XVII.I).
Data availability
The datasets generated or analyzed during the 




BDNF: brain-derived neurotrophic factor; BoNT/A: 
Botulinum Toxin A; BoNT/C1: Botulinum Toxin C1; 
DRG: dorsal root ganglion; NGF: Nerve growth factor; 
Nrp1: Neuropilin 1; NT-3: neurotrophin-3; NT-4: 
neurotrophin-4; PlexA1: Plexin A1; PTB: phosphotyrosine 
binding; Sema3A: Semaphorin 3A; SH2: Src-homology-2; 
SNAP25: 25-kDa soluble N-ethylmaleimide-sensitive 
factor attachment protein; Sytx1: Syntaxin 1; TeNT: 
tetanus toxin; TI-VAMP: Tetanus Neurotoxin Insensitive 
Vesicle-Associated Membrane Protein; Trk: tropomyosin-
related kinase; VAMP2: Vesicle-associated membrane 
protein 2.
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